Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2018 | 01-2018 | 10-2017 | 07-2017 | 04-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,829 | -5,533 | -3,503 | -1,688 | -4,444 |
| Accounts payable and accrued liabilities | -13 | -60 | -55 | 263 | 30 |
| Other Working Capital | -86 | 372 | 31 | 309 | -21 |
| Other Operating Activity | 1,848 | 1,516 | 994 | 182 | 1,096 |
| Operating Cash Flow | $-5,079 | $-3,705 | $-2,532 | $-936 | $-3,340 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,681 | 1,751 | 1,751 | 1,751 | 4,882 |
| Financing Cash Flow | $2,681 | $1,751 | $1,751 | $1,751 | $4,882 |
| Exchange Rate Effect | -6 | -3 | -2 | -2 | 1 |
| Beginning Cash Position | 3,464 | 3,464 | 3,464 | 3,464 | 1,921 |
| End Cash Position | 1,060 | 1,508 | 2,682 | 4,278 | 3,464 |
| Net Cash Flow | $-2,404 | $-1,956 | $-782 | $543 | $1,543 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,079 | -3,705 | -2,532 | -936 | -3,340 |
| Free Cash Flow | -5,079 | -3,705 | -2,532 | -936 | -3,340 |